Report by Polaris Market Research

NEW YORK, May 22, 2023 /PRNewswire/ — A latest research report [115+] pages with 360-Degree visibility, titled “Bio-implant Market Size, Share & Trends Analysis Report by Product (Cardiovascular, Orthopedic, Dental, Spinal), By Material (Ceramics, Polymers, Biomaterial Metal, Alloys) Segment Forecasts, 2023 – 2032” published by Polaris Market Research in its research repository. “According to research … Read more

Produtos por assinatura chegam ao mercado de seguros

Setor deve ganhar novidades em breve nos ramos Patrimonial, Saúde, Auto e Residência SÃO PAULO, 22 de maio de 2023 /PRNewswire/ — Os clubes de assinatura – modelo de negócio que entrega produtos ou serviços periodicamente mediante um pagamento recorrente – tem crescido em todo país. Já estabelecidos com sucesso em diferentes nichos do mercado … Read more

Avalon Healthcare Solutions Names Pamela Stahl as President

TAMPA, Fla., May 22, 2023 /PRNewswire/ — Avalon Healthcare Solutions, the world’s first Lab Insights company, named Pamela Stahl, a highly experienced healthcare leader, as President. As part of the Avalon executive team, Stahl will lead the company’s continued growth with national and multi-state health plans and strategic partnerships. Stahl has an extensive healthcare background … Read more

Dental Digital X-ray Market to Reach $7.2 Billion, Globally, by 2032 at 8.5% CAGR: Allied Market Research

The global dental digital X-ray market is driven by factors such as surge in prevalence of dental diseases, technological advancements in dental digital X-ray systems and increase in geriatric population. PORTLAND, Ore., May 22, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Dental Digital X-ray Market by Type (Extraoral X-ray System and Intraoral X-ray System), … Read more

Ken Reali, Renowned Healthcare Executive, Joins NeoLight’s Board of Directors

NeoLight enhances its leadership team with the appointment of seasoned medical device executive Ken Reali, bringing valuable industry experience to the Board of Directors. SCOTTSDALE, Ariz., May 22, 2023 /PRNewswire/ — NeoLight is pleased to announce the appointment of Ken Reali, a respected healthcare executive, to its Board of Directors. With an illustrious career spanning … Read more

Penn Dental Medicine Launches Educational Video Series, Podcast on Statistical Concepts

PHILADELPHIA, May 22, 2023 /PRNewswire/ — The Penn Dental Medicine Center for Integrative Global Oral Health (CIGOH) has launched  “Statistics with Crayons”, a new animated video and podcast series aimed at making complex statistical concepts accessible to the general public. The series is produced by the Penn Dental Medicine Center for Educational Technology & Innovation (CETI). Led … Read more

ATCOR Launches New 2,000-Patient Longitudinal Retrospective Study for Heart Health

“Gold Standard” SphygmoCor® Technology to be Used to Identify Care Outcomes Associated with Routine Monitoring of Patients with Elevated Blood Pressure IRVINE, Calif., May 22, 2023 /PRNewswire/ — ATCOR Medical, a subsidiary of CardieX and developer of innovative medical devices and digital health solutions to optimize hypertension management and improve clinical trial patient outcomes, today announced it has … Read more

Pierre Fabre gibt den Beginn des EU-Zulassungsverfahrens für Vibegron zur Behandlung überaktiver Blasen bekannt

CASTRES, Frankreich, 22. Mai 2023 /PRNewswire/ — Im Anschluss an die exklusive Lizenzvereinbarung mit der Urovant Sciences GmbH gab Pierre Fabre heute den Beginn des EU-Zulassungsverfahrens (zentralisiertes Verfahren) für Vibegron bekannt. Vibegron ist ein neuartiger, potenter und selektiver humaner Beta-3-Adrenozeptor-Agonist (β3-AR-Agonist), der eine Muskelentspannung herbeiführt, um die Blasenkapazität zu erhöhen und die Symptome einer überaktiven … Read more

Pierre Fabre anuncia su solicitud de autorización de comercialización en la UE de Vibegron para el tratamiento de la vejiga hiperactiva

CASTRES, Francia, 22 de mayo de 2023 /PRNewswire/ — Tras el acuerdo de licencia exclusiva con Urovant Sciences GmbH, Pierre Fabre anuncia hoy el inicio del procedimiento de solicitud para la autorización de comercialización en la UE (procedimiento centralizado) de Vibegron, un nuevo, potente y selectivo agonista del receptor adrenérgico β3 humano (β 3-AR) que … Read more

Pierre Fabre announces start of EU marketing authorization application procedure for Vibegron in overactive bladder

CASTRES, France, May 22, 2023 /PRNewswire/ — Following the exclusive licensing agreement with Urovant Sciences GmbH, Pierre Fabre announced today the start of the EU marketing authorization application procedure (centralized procedure) for Vibegron, a novel, potent, and selective human β3 adrenergic receptor (β 3-AR) agonist inducing muscle relaxation to increase bladder capacity and relieve symptoms … Read more